![]() |
RELATED RESOURCES |
SEC Filings:ENZNENZON PHARMACEUTICALS INC0.30095
|
Year | Type ![]() |
![]() |
Period End Date | |
---|---|---|---|---|
2019 | Form SC 13G/A | Beneficial Ownership Statement | 01/03/2019 | N/A |
Form SC 13G/A | Beneficial Ownership Statement | 01/03/2019 | N/A | |
2018 | Form 10-Q* | Quarterly Report* | 11/07/2018 | 09/30/2018 |
Form 8-K* | Current Report* | 08/13/2018 | 08/09/2018 | |
Form 10-Q* | Quarterly Report* | 08/10/2018 | 06/30/2018 | |
Form DEFA14A | Definitive Proxy Statements | 06/29/2018 | N/A | |
Form DEF 14A | Definitive Proxy Statements | 06/29/2018 | 08/09/2018 | |
Form DEFA14A | Definitive Proxy Statements | 06/29/2018 | N/A | |
Form DEFA14A | Definitive Proxy Statements | 06/29/2018 | N/A | |
Form 10-Q* | Quarterly Report* | 05/10/2018 | 03/31/2018 | |
2017 | Form 10-K/A* | Annual Report* | 04/25/2018 | 12/31/2017 |
2018 | Form 3 | Insider Initial Filing | 04/13/2018 | 04/04/2018 |
Form SC 13G/A | Beneficial Ownership Statement | 04/13/2018 | N/A | |
Form SC 13G/A | Beneficial Ownership Statement | 04/13/2018 | N/A | |
Form SC 13G/A | Beneficial Ownership Statement | 04/13/2018 | N/A |